Gene · 29927
Papers2,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways. | Front Immunol | 2023 | 37790926 | PubTator, text mining | PubMed |
| Identification of prognostic and diagnostic signatures for cancer and acute myocardial infarction: multi-omics approaches for deciphering heterogeneity to enhance patient management. | Front Pharmacol | 2023 | 37781709 | PubTator, text mining | PubMed |
| ULK1 forms distinct oligomeric states and nanoscopic structures during autophagy initiation. | Sci Adv | 2023 | 37774021 | PubTator, text mining | PubMed |
| The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication. | J Virol | 2023 | 37768083 | PubTator, text mining | PubMed |
| Quantitative Mass Spectrometry Characterizes Client Spectra of Components for Targeting of Membrane Proteins to and Their Insertion into the Membrane of the Human ER. | Int J Mol Sci | 2023 | 37762469 | PubTator, text mining | PubMed |
| Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease. | Genes (Basel) | 2023 | 37761895 | PubTator, text mining | PubMed |
| Analysis of proteome and post-translational modifications of 2-hydroxyisobutyrylation reveals the glycolysis pathway in oral adenoid cystic carcinoma. | World J Surg Oncol | 2023 | 37741973 | PubTator, text mining | PubMed |
| Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer. | Sci Rep | 2023 | 37739987 | PubTator, text mining | PubMed |
| Mechanistic characterization of disulfide bond reduction of an ERAD substrate mediated by cooperation between ERdj5 and BiP. | J Biol Chem | 2023 | 37739037 | PubTator, text mining | PubMed |
| Nuclear epidermal growth factor receptor as a therapeutic target. | Explor Target Antitumor Ther | 2023 | 37720348 | PubTator, text mining | PubMed |
| ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover. | Protein Cell | 2023 | 37707322 | PubTator, text mining | PubMed |
| ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones. | Int J Biol Sci | 2023 | 37705743 | PubTator, text mining | PubMed |
| Plasmodium falciparum GCN5 plays a key role in regulating artemisinin resistance-related stress responses. | Antimicrob Agents Chemother | 2023 | 37702516 | PubTator, text mining | PubMed |
| Closer to the Reality-Proteome Changes Evoked by Endometrial Scratching in Fertile Females. | Int J Mol Sci | 2023 | 37686380 | PubTator, text mining | PubMed |
| Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. | Science | 2023 | 37676964 | PubTator, text mining | PubMed |
| Triaging of α-helical proteins to the mitochondrial outer membrane by distinct chaperone machinery based on substrate topology. | bioRxiv | 2023 | 37645817 | PubTator, text mining | PubMed |
| Spf1 and Ste24: quality controllers of transmembrane protein topology in the eukaryotic cell. | Front Cell Dev Biol | 2023 | 37635876 | PubTator, text mining | PubMed |
| A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases. | Genes (Basel) | 2023 | 37628633 | PubTator, text mining | PubMed |
| Mycolactone A vs. B: Multiscale Simulations Reveal the Roles of Localization and Association in Isomer-Specific Toxicity. | Toxins (Basel) | 2023 | 37624243 | PubTator, text mining | PubMed |
| Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer. | J Inflamm Res | 2023 | 37593196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29927/papers?page=8